Rani Therapeutics Holdings Inc (NAS:RANI)

$ 1.42 0 (0%) Market Cap: 47.30 Mil Enterprise Value: 53.28 Mil PE Ratio: 0 PB Ratio: 13.52 GF Score: 30/100

Q4 2023 Rani Therapeutics Holdings Inc Earnings Call Transcript
Mar 20, 2024

$3.57 (+0.56%)

Earnings
Rani Therapeutics Holdings Inc To discuss the results from its Phase 1 clinical trial of RT-111. Transcript
Feb 05, 2024
Rani Therapeutics Holdings Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 28, 2023
Rani Therapeutics Holdings Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Rani Therapeutics Holdings Inc at H.C. Wainwright BioConnect Investor Conference Transcript
May 02, 2023
Rani Therapeutics Holdings Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 18, 2023
Q4 2022 Rani Therapeutics Holdings Inc Earnings Call Transcript
Mar 22, 2023

$5.95 (-1.00%)

Earnings
Rani Therapeutics Holdings Inc To Discuss The Topline Results From The Phase 1 Part 2 Repeat Dose Study of RT-102 Call Transcript
Dec 06, 2022
Rani Therapeutics Holdings Inc at Stifel Healthcare Conference Transcript
Nov 16, 2022
Rani Therapeutics Holdings Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 14, 2022

Q4 2023 Rani Therapeutics Holdings Inc Earnings Call Transcript

Mar 20, 2024 / 08:30PM GMT

Release Date Price: $3.57 (+0.56%)

Transcript 10-K8-K

Operator

Welcome to the Rani therapeutics, both fourth quarter and full year 2023 financial results and corporate update conference call. At this time, all participants are in a listen only mode. (Operator Instructions)

As a reminder, this call is being recorded today, Wednesday, March 20, 2024. I would now like to turn the conference call over to Keith Patel at Gilmartin Group. Please go ahead.

Kiki Patel

Gilmartin Group LLC - IR

Thank you, operator. Joining us on the call today from Rani Therapeutics, are Chief Executive Officer Talat Imran; VP of Clinical Development, Arvinder Dhalla; and Chief Financial Officer, Svai Sanford.

During this conference call, management will make forward-looking statements that are subject to risks, uncertainties and assumptions such as but not limited to, those discussed in the Risk Factors section and the company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K and quarterly reports on Form 10-Q, which identify the specific factors that may cause actual results or

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.